Polypharmacy and Potentially Inappropriate Medication in the Adult, Community-Dwelling Population in Switzerland
- 487 Downloads
Polypharmacy and potentially inappropriate medication (PIM) are associated with adverse outcomes such as hospitalization, loss of productivity, and death.
This study evaluates the prevalence of polypharmacy and PIM in the adult community-dwelling population in Switzerland.
The analysis is done based on claims data from the largest health insurance in Switzerland. We calculated the number of medications submitted for reimbursement, the proportion of persons with polypharmacy, and the proportion of persons receiving PIM according to the 2003 Beers criteria and the PRISCUS list. Additionally, we estimated cost for medications and PIM, and identified the most prevalent groups of PIM according to the Anatomical Therapeutic Chemical Classification System (ATC).
17 % of the adult community-dwelling population in Switzerland received 5 or more medications which is one of the common definitions of polypharmacy, and over 21 % of adults aged more than 65 years had a PIM according to 2003 Beers criteria or the PRISCUS list. The most prevalent classes of PIM were psycholeptics, sex hormones, psychoanaleptics, and antiinflammatory drugs.
Although the present study has a number of limitations, we conclude that the prevalence of polypharmacy and PIM in Switzerland is high. A broad spectrum of interventions on the individual level as well as on the population level is urgently needed.
KeywordsNursing Home Resident Anatomical Therapeutic Chemical Classification Beers Criterion Basic Health Insurance Receive Home Care
The study was funded by own resources of the Helsana group and the Swiss Center for Telemedicine Medgate. The sponsors had no role in the design and conduct of the study nor in the decision to submit this manuscript.
Conflicts of interest
- 1.World Health Organization, Medicines: safety of medicines—adverse drug reactions, Fact sheet No 293 [online]. 2008. http://www.who.int/mediacentre/factsheets/fs293/en/index.html. Accessed 04 Oct 2012.
- 16.Haider SI, Johnell K, Thorslund M, Fastbom J. Trends in polypharmacy and potential drug–drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Therap. 2007;45(12):643–53.Google Scholar
- 20.Federal Office of Public Health. Bundesgesetz vom 18. März 1994 über die Krankenversicherung (KVG) [online]. http://www.admin.ch/ch/d/sr/c832_10.html. Accessed 04 Oct 2012.
- 22.World Health Organization. ATC/ DDD Index 2012 [online]. http://www.whocc.no/atc_ddd_index/. Accessed 04 Oct 2012.
- 24.Interpharma. Pharma-Markt Schweiz 2012 [online]. http://www.interpharma.ch/de/fakten-und-statistiken/Pharma-Markt-Schweiz.asp. Accessed 04 Oct 2012.
- 33.Organisation for Economic Co-operation and Development. OECD Reviews of Health Systems—Switzerland [online]. http://www.oecd.org/health/healthpoliciesanddata/oecdreviewsofhealthsystems-switzerland.htm. Accessed 04 Oct 2012.